Skip to main content
. 2015 Jun 23;10(6):e0130391. doi: 10.1371/journal.pone.0130391

Table 1. Vaccine formulations in each group.

Group rHspA(μg) rGGT(μg) rHspA-GGT(μg) LTB(μg) CpG(μg) Total volume(μl)
PBS 0 0 0 0 0 20
CpG 0 0 0 0 10 20
LTB 0 0 0 10 0 20
rHspA+LTB 30 0 0 10 0 20
rGGT+LTB 0 30 0 10 0 20
rHspA-GGT+LTB 0 0 30 10 0 20
rHspA-GGT+CpG 0 0 30 0 10 20
rHspA-GGT 0 0 30 0 0 20